Program Schedule

184
Clinical Trials

Saturday, October 11, 2014: 10:30 AM-12:00 PM
Room: The Pennsylvania Convention Center: 109-AB

Learning Objectives:

-

Target Audience: Vaccinologists, Scientists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Medical students and residents, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, Hospital administrators, HIV specialists, HIV clinicians, Health care workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Adult ID

Moderator:  Sheldon L. Kaplan, MD, FIDSA, Baylor College of Medicine and Texas Children's Hospital

Presentations:
10:30 AM
1331
The SOLO Studies:  A Single-Dose of Oritavancin (ORI) Compared to 7-10 Days of Vancomycin (VAN) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Ralph Corey, MD ; Matthew Wikler, MD ; Greg Moeck ; Hai Jiang ; Samantha Good
10:45 AM
1332
A Randomized, Double-Blind, Placebo-Controlled Trial of Trimethoprim-sulfamethoxazole vs. Placebo for Patients with an Incised and Drained Cutaneous Abscess
David Talan, MD. FIDSA, FACEP ; William Mower, MD, PhD ; Fredrick Abrahamian, D.O. ; Anusha Krishnadasan, PhD ; Frank Lovecchio, DO, MPH ; David Karras, MD ; Mark Steele, MD ; Richard Rothman, MD, PhD ; Gregory Moran, MD, FIDSA, FACEP
11:00 AM
1333
Therapeutic HSV-2 vaccine (GEN003) results in durable reduction in genital lesions at 1 year
Anna Wald, MD, MPH, FIDSA ; Terri Warren, ANP ; Kenneth Fife, MD, PhD ; Stephen Tyring, MD, PhD ; Patricia Lee, M.D. ; Nicholas Van Wagoner, MD, PhD ; David Bernstein, MD ; Jessica B. Flechtner, PhD ; Amalia Magaret, PhD ; Amy Morris ; Seth Hetherington, M.D.
11:15 AM
1334
Randomized Clinical Trial of Viral Testing and Serum Procalcitonin to Reduce Antibiotic Use for Respiratory Infections
Angela Branche, MD ; Edward Walsh, MD, FIDSA ; Ann Falsey, MD ; Roberto L. Vargas, MD ; Barbara Hulbert, ASCP
11:30 AM
1335
Transfer and Persistence of Antibodies in Infants Following Maternal Immunization with an Investigational Trivalent Group B Streptococcus Vaccine
Scott A Halperin ; Gilbert Donders ; Roland Devlieger ; Sherryl Baker ; Pietro Forte ; Frederick Wittke ; Karen Slobod, MD ; Peter M Dull, MD
11:45 AM
1336
A Randomized Controlled Trial of the Effect of Total Household Decolonization on Termination of Colonization with Methicillin-Resistant Staphylococcus aureus
Valerie C. Cluzet, MD ; Jeffrey S. Gerber, MD, PhD ; Joshua Metlay, MD, PhD ; Irving Nachamkin, DrPH, MPH ; Theoklis Zaoutis, MD, MSCE ; Kathleen G. Julian, MD ; Darren R. Linkin, MD, MSCE ; Susan E. Coffin, MD, MPH ; David J. Margolis, MD, PhD ; Judd E. Hollander, MD ; Warren Bilker, PhD ; Xiaoyan Han, MS ; Rakesh D. Mistry, MD, MS ; Laurence J. Gavin, MD ; Pam Tolomeo, MPH ; Jacqueleen Wise ; Mary K. Wheeler, MBE ; Baofeng Hu ; Neil O. Fishman, MD ; David Royer, PhD ; Ebbing Lautenbach, MD, MPH, MSCE

CME Credits:

ACPE Credits:

ACPE Number:

Disclosures:

S. L. Kaplan, Pfizer: Grant Investigator and Scientific Advisor, Consulting fee and Grant recipient

See more of: Oral Abstract Session
<< Previous Session | Next Session >>

Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

Sponsoring Societies:

© 2014, idweek.org. All Rights Reserved.

Follow IDWeek